The Opiate Antagonist, Naltrexone, in the Treatment of Trichotillomania

2014 ◽  
Vol 34 (1) ◽  
pp. 134-138 ◽  
Author(s):  
Jon E. Grant ◽  
Brian L. Odlaug ◽  
Liana R.N. Schreiber ◽  
Suck Won Kim
Keyword(s):  
Opiate Antagonist

Induction of ovulation with the opiate antagonist naltrexone in hypothalamic amenorrhea

1987 ◽  
Vol 116 (3_Suppl) ◽  
pp. S166
Author(s):  
L. WILDT ◽  
G. LEYENDECKER ◽  
M. WINGENDORF ◽  
J. KÖLN
Keyword(s):  
Opiate Antagonist ◽  
Hypothalamic Amenorrhea ◽  
Induction Of Ovulation

Craving in Heroin Addicts Maintained on the Opiate Antagonist Naltrexone

1978 ◽  
Vol 5 (4) ◽  
pp. 415-423 ◽  
Author(s):  
Stephen I. Sideroff ◽  
V. C. Charuvastra ◽  
Murray E. Jarvik ◽  
Jan Ouren
Keyword(s):  
Opiate Antagonist ◽  
Heroin Addicts

Treatment of Antidepressant-Resistant Bulimia with Naltrexone

1987 ◽  
Vol 16 (4) ◽  
pp. 305-309 ◽  
Author(s):  
Jeffrey M. Jonas ◽  
Mark S. Gold
Keyword(s):  
Eating Disorders ◽  
Preliminary Data ◽  
Endogenous Opioids ◽  
Opiate Antagonist ◽  
Percent Reduction ◽  
Bulimic Symptoms ◽  
Long Acting ◽  
Insight Into

Ten individuals with antidepressant-resistant bulimia were treated with the long-acting opiate antagonist naltrexone. Seven of the ten experienced at least a 75 percent reduction of their bulimic symptoms, and have maintained their improvment on three to five month follow-up. These preliminary data suggest that naltrexone may be of use in bulimia unresponsive to standard antidepressant therapy, and may provide insight into the role of endogenous opioids in the etiology of eating disorders.

The opiate antagonist naloxone suppresses a rodent model of tardive dyskinesia

1993 ◽  
Vol 8 (4) ◽  
pp. 445-452 ◽  
Author(s):  
A. Jon Stoessl ◽  
Elizabeth Polanski ◽  
Hanna Frydryszak
Keyword(s):  
Tardive Dyskinesia ◽  
Rodent Model ◽  
Opiate Antagonist
Sign in / Sign up

Export Citation Format

Share Document